Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2025-07-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
第九届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 15th meeting of the 9th Board of Directors of the company. It includes voting results on various internal governance matters such as amendments to management rules, committee work rules, and share repurchase plans. It also mentions upcoming shareholder meetings and references other related announcements. The content focuses on board decisions and governance structure changes rather than financial results or reports. The document length is 2579 characters, which is relatively short but contains substantive board meeting resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. It is not a full financial report, audit, or regulatory filing, nor is it a simple announcement of a report publication. Therefore, the appropriate classification is MANG with high confidence.
2025-07-11 Chinese
《董事会议事规则》（2025年7月）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors'. It details the governance structure, qualifications, duties, meeting procedures, and powers of the board of directors of the company. It includes sections on board composition, independent directors, board secretary, meeting notification and voting procedures, and other governance-related rules. There is no financial data, audit information, or report content. The document is a governance framework document, not a financial report or announcement. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, confirming it is the actual governance document, not an announcement or summary.
2025-07-11 Chinese
关于召开2025年第三次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2025 third extraordinary general meeting of shareholders for Chongqing Pharmaceutical Holdings Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), agenda items such as amendments to company bylaws and share repurchase proposals, and instructions for proxy voting. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and voting process. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2025-07-11 Chinese
《独立董事管理办法》（2025年7月）
Governance Information Classification · 95% confidence The document is titled '独立董事管理办法' which translates to 'Independent Director Management Measures'. It details the rules, qualifications, duties, and procedures related to independent directors within the company. The content focuses on governance practices, board structure, director responsibilities, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication announcement. The document is a governance-related policy or internal rules document. Therefore, it fits best under the category of Governance Information (CGR).
2025-07-11 Chinese
第八届监事会第三十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of the company 重药控股股份有限公司. It details the meeting date, attendance, and voting results on several proposals including the cancellation of the supervisory board, amendments to the company charter, and a share repurchase plan. The document is short (789 characters) and serves as an official announcement of board decisions rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed management discussion. It is not a report publication announcement since it contains substantive meeting resolutions. The content fits best under Board/Management Information (MANG) as it announces changes in company governance and management structure.
2025-07-11 Chinese
《提名委员会工作细则》（2025年7月）
Governance Information Classification · 95% confidence The document is titled as the 'Board Nomination Committee Working Rules' of a company, detailing the structure, responsibilities, and procedures of the board nomination committee. It focuses on governance practices, committee composition, meeting rules, and nomination processes for directors and senior management. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal rules document, fitting the Governance Information (CGR) category.
2025-07-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.